Research of Pathogenesis and Novel Therapeutics in Arthritis

Tang, Chih-Hsin

doi:10.3390/books978-3-03897-066-8

dc.contributor.author	Tang, Chih-Hsin	*
dc.date.accessioned	2021-02-12T01:59:33Z
dc.date.available	2021-02-12T01:59:33Z
dc.date.issued	2019	*
dc.date.submitted	2019-06-26 08:44:06	*
dc.identifier	33667	*
dc.identifier.uri	https://directory.doabooks.org/handle/20.500.12854/58295
dc.description.abstract	Arthritis has a high prevalence globally and includes over 100 different types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis, and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly used in the treatment of arthritis but are associated with significant side effects. Novel modes of therapy and additional prognostic biomarkers are urgently needed for arthritis patients. This book summarizes and discusses the global picture of the current understanding of arthritis.	*
dc.language	English	*
dc.subject	R5-920	*
dc.subject	RM1-950	*
dc.subject.classification	thema EDItEUR::M Medicine and Nursing	en_US
dc.subject.other	receptor activator of nuclear factor ?B	*
dc.subject.other	infliximab	*
dc.subject.other	tripterine	*
dc.subject.other	triptolide	*
dc.subject.other	osteoblast	*
dc.subject.other	tumor necrosis factor-alpha	*
dc.subject.other	synovial cell	*
dc.subject.other	anti-arthritis	*
dc.subject.other	biosimilars	*
dc.subject.other	Epstein-Barr virus	*
dc.subject.other	cytokines	*
dc.subject.other	SOX9	*
dc.subject.other	parathyroid hormone	*
dc.subject.other	nitric oxide	*
dc.subject.other	rat	*
dc.subject.other	etanercept	*
dc.subject.other	angiogenesis	*
dc.subject.other	glycosylation	*
dc.subject.other	mitogen activated protein kinase	*
dc.subject.other	Th9 lymphocytes	*
dc.subject.other	rheumatoid arthritis	*
dc.subject.other	IL-6	*
dc.subject.other	clodronate	*
dc.subject.other	bone erosion	*
dc.subject.other	mesenchymal stem cells	*
dc.subject.other	collagen-induced arthritis	*
dc.subject.other	biological	*
dc.subject.other	gene expression	*
dc.subject.other	inflammatory arthritis	*
dc.subject.other	osteoarthritis	*
dc.subject.other	fraxinellone	*
dc.subject.other	nuclear factor kappa B	*
dc.subject.other	messenger RNA	*
dc.subject.other	inflammation	*
dc.subject.other	miRNA	*
dc.subject.other	disease-modifying	*
dc.subject.other	adipokines	*
dc.subject.other	WNT	*
dc.subject.other	glycoprotein 42	*
dc.subject.other	miR-199a-5p	*
dc.subject.other	proliferation	*
dc.subject.other	next-generation sequencing	*
dc.subject.other	collagen	*
dc.subject.other	osteoarthritis (OA)	*
dc.subject.other	experimental arthritis	*
dc.subject.other	bone morphogenetic protein	*
dc.subject.other	TNF-?	*
dc.subject.other	computational modeling	*
dc.subject.other	basic research	*
dc.subject.other	osteoclast	*
dc.subject.other	therapeutics	*
dc.subject.other	certolizumab pegol	*
dc.subject.other	chondrocytes	*
dc.subject.other	progenitor cells	*
dc.subject.other	adjuvant arthritis	*
dc.subject.other	adalimumab	*
dc.subject.other	triterpenoid	*
dc.subject.other	sclareol	*
dc.subject.other	TNF?	*
dc.subject.other	fibroblast growth factor 2	*
dc.subject.other	antibodies	*
dc.subject.other	osteoblasts	*
dc.subject.other	molecular pathology	*
dc.subject.other	Th17	*
dc.subject.other	immunology	*
dc.subject.other	obesity	*
dc.subject.other	visfatin	*
dc.subject.other	articular cartilage	*
dc.subject.other	autoimmune	*
dc.subject.other	biomarkers	*
dc.subject.other	celastrol	*
dc.subject.other	MAPK	*
dc.subject.other	disease pathways	*
dc.subject.other	IL1?	*
dc.subject.other	arthritis	*
dc.subject.other	bioinformatics	*
dc.subject.other	anticitrullinated peptide antibodies	*
dc.subject.other	drug delivery system	*
dc.subject.other	antagonists	*
dc.subject.other	shared epitope	*
dc.subject.other	pathology	*
dc.subject.other	SMA- and MAD-related protein	*
dc.subject.other	small-molecule inhibitor	*
dc.subject.other	transforming growth factor ?	*
dc.subject.other	mice	*
dc.subject.other	golimumab	*
dc.subject.other	spinal fusion	*
dc.subject.other	antirheumatic drug	*
dc.subject.other	early osteoarthritis	*
dc.subject.other	stem cell	*
dc.subject.other	rheumatoid factor	*
dc.subject.other	therapeutic antibody	*
dc.subject.other	bisphosphonate	*
dc.subject.other	osteoclastogenesis	*
dc.subject.other	interleukin	*
dc.subject.other	spondyloarthropathies	*
dc.subject.other	clinical translation	*
dc.subject.other	therapy	*
dc.subject.other	Traditional Chinese medicine	*
dc.subject.other	chemokines	*
dc.subject.other	structure	*
dc.subject.other	cell signaling	*
dc.subject.other	microRNA	*
dc.title	Research of Pathogenesis and Novel Therapeutics in Arthritis	*
dc.type	book
oapen.identifier.doi	10.3390/books978-3-03897-066-8	*
oapen.relation.isPublishedBy	46cabcaa-dd94-4bfe-87b4-55023c1b36d0	*
oapen.relation.isbn	9783038970651	*
oapen.relation.isbn	9783038970668	*
oapen.pages	366	*
oapen.edition	1st	*

Files in this item

Files	Size	Format	View
There are no files associated with this item.

This item appears in the following Collection(s)

Imported or submitted locally

Show simple item record

Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/